MLKL and breast carcinoma: Although phosphorylated MLKL (p-MLKL) detection via immunohistochemistry has been reported in various human cancers (e.g., colorectal and breast carcinomas) as a surrogate readout for necroptosis, its specificity and reliability remain challenged.